OCUPHIRE PHARMA INC (OCUP)

US67577R1023 - Common Stock

1.64  +0.05 (+3.47%)

After market: 1.61 -0.03 (-1.83%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
590K39.85M
6,654.24%		19.049M
-52.20%		26.561M
39.44%
EBITDA
YoY % growth
N/AN/A-10.557M-19.89M
-88.41%
EBIT
YoY % growth
-22.7M
-139.96%		18.23M
180.31%		-10.563M
-157.94%		-8.823M
16.47%
Operating Margin
-3,847.46%45.75%-55.45%-33.22%
EPS
YoY % growth
-1.59
74.68%		0.76
147.80%		-0.48
-163.16%		-0.31
34.97%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.14
51.19%
Revenue
Q2Q % growth		4.337M
147.83%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-3.616M
41.01%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.21
-113.29%		-0.05-0.16-292.16%
Q3 2023
Q2Q % growth		 0.25
213.64%		-0.230.48210.40%
Q2 2023
Q2Q % growth		 -0.24
4.00%		-0.23-0.01-4.11%
Q1 2023
Q2Q % growth		 -0.28
20.00%		-0.16-0.12-78.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 1.691M
-95.76%		5.456M-3.765M-69.01%
Q3 2023
Q2Q % growth		 11.94M
∞%		3.086M8.854M286.91%
Q2 2023
Q2Q % growth		 3.67M
∞%		2.474M1.196M48.34%
Q1 2023
Q2Q % growth		 1.75M
∞%		3.01M-1.26M-41.86%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -34% -33.04% -33.04%
Revenue0% -18.23% -8.74% -8.74%